Tech Company Financing Transactions

Navitor Pharmaceuticals Funding Round

Navitor Pharmaceuticals, operating out of Cambridge, secured $23.5 million in investment from Atlas Venture, Johnson & Johnson Development Corporation and Longevity Fund.

Transaction Overview

Company Name
Navitor Pharmaceuticals
Announced On
6/20/2014
Transaction Type
Venture Equity
Amount
$23,500,000
Round
Series A
Investors

Atlas Venture (Jean-François Formela)

Johnson & Johnson Development Corporation (Marian Nakada)

Longevity Fund

Polaris Partners (Alan Crane)

SR One Capital Management (Brian Gallagher)

Proceeds Purpose
Proceeds from the financing will be used to augment Navitor's proprietary drug discovery platform and accelerate the development of a pipeline of novel drugs that target cellular nutrient signaling via the mTORC1 pathway to address a wide range of diseases, including metabolic.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1030 Massachusetts Ave. 410
Cambridge, MA 02138
USA
Phone
(781) 258-6153
Website
www.navitorpharma.com
Email Address
[email protected]
Overview
New scientific insights are emerging regarding the primal signaling pathways that direct an organism's metabolic response to conditions in its environment--such as dynamic changes in the availability of nutrients, energy, oxygen and other factors--and the role of these metabolic signaling pathways in disease.
Profile
Navitor Pharmaceuticals LinkedIn Company Profile
Social Media
Navitor Pharmaceuticals Company Twitter Account
Company News
Navitor Pharmaceuticals News
Facebook
Navitor Pharmaceuticals on Facebook
YouTube
Navitor Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Thomas Hughes
  Thomas Hughes LinkedIn Profile  Thomas Hughes Twitter Account  Thomas Hughes News  Thomas Hughes on Facebook
Chief Medical Officer
James Owen
  James Owen LinkedIn Profile  James Owen Twitter Account  James Owen News  James Owen on Facebook
VP - Bus. Development
Rick Lundberg
  Rick Lundberg LinkedIn Profile  Rick Lundberg Twitter Account  Rick Lundberg News  Rick Lundberg on Facebook
VP - R & D
Eddine Saiah
  Eddine Saiah LinkedIn Profile  Eddine Saiah Twitter Account  Eddine Saiah News  Eddine Saiah on Facebook

 

 

Browse more venture capital transactions:

Prev: 6/20/2014: IssuWorks venture capital transaction
Next: 6/20/2014: JHL Biotech venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.